About Us
The 7th Ace Drug Discovery Summit USA 2026 is a premier scientific forum uniting global researchers, biotech leaders, and pharma innovators to explore the latest advancements transforming drug discovery. This two-day summit features cutting-edge sessions on AI-driven drug design, quantum computing in simulation, targeted protein degradation, RNA therapeutics, and sustainable medicinal chemistry. Key discussions will highlight CAR-T cell therapies, immunotherapy combinations, bioinformatics, and nanomedicine, reflecting the evolving landscape of pharmaceutical R&D. Attendees will gain actionable insights into emerging technologies, fragment-based drug design, and AI-powered screening, with a strong focus on unmet medical needs and ethical considerations. With interactive panel discussions, expert-led presentations, and exclusive business meetings, the summit fosters meaningful collaboration and knowledge exchange across the drug development spectrum. Join us to stay at the forefront of innovation and reshape the future of drug discovery and therapeutic development.
Why Attend





Solutions at ADDS
The 7th Ace Drug Discovery Summit USA 2026 is a premier scientific forum uniting global researchers, biotech leaders, and pharma innovators to explore the latest advancements transforming drug discovery.
🔷Antibody Engineering
🔷Biochemistry
🔷Bio-informatics
🔷ADMUPI (Toxicology)
🔷Biomarker Validation
🔷Combinatorial Chemistry
🔷Covering Biological studies
🔷Data Management TechnologyÂ
🔷Digital Imaging Technology
🔷Discovery Outsourcing Services
🔷DNA & RNA Analysis
🔷DNA Sequencing Services
🔷 Drug Discovery Technology Platforms
🔷Gene Expression Profiling Solutions
🔷Preclinical
🔷Principal Scientists
🔷Protein identification Services
🔷Research & Development
🔷Transgenesis Services
🔷Genomics
🔷High Throughput Screening
🔷Lead Optimatisation and Profiling, HTS
🔷 Licensing
🔷lmaging/biomarker
🔷Imaging Tools
Who Will Attend
The 7th Ace Drug Discovery Summit USA 2026 is a premier scientific forum uniting global researchers, biotech leaders, and pharma innovators to explore the latest advancements transforming drug discovery
🔷CEO
🔷CSO
🔷Director Discovery Alliances
🔷Director of Discovery Strategy Portfolio
🔷Director of Screening & Compound   Profiling
🔷Executive Director Chemistry
🔷Head of DMPK
🔷Head of Drug Design
🔷Head of Molecular Toxicology
🔷VP Target Discovery & Assessment
🔷Head of R&D Licensing
🔷Head Pharmacology & Toxicology
🔷Principal Scientist
🔷Senior Director Discovery Research
Thought Leaders
Ana Vergara
Senior Scientist DMPK
| Merck
Michael Tolentino
Co-Founder, Board Member , Chief Innovation Officer | Aviceda Therapeutics
Shipra Malhotra
Senior Scientist, Biologics, Computational Biology / Machine Learning | Takeda
Jason Noon
Principal Research Scientist II, Head of Tissue Resident T cell Biology | AbbVie
Christin Glorioso
CEO & Co-founder |
NeuroAge Therapeutics
Dinesh Chandra
Associate Director |
Johnson & Johnson
Sundar Jubilant
Senior Scientist |
Arrakis Therapeutics
Tomi Sawyer
Chief Drug Hunter |
Maestro Therapeutics
Even Walseng
Director |
AstraZeneca
Zhinan Xia
CSO |
Abimmune Bio
Igor Nasonkin
CEO |
Phythera Therapeutics
Anil Karihaloo
Sr Principal Res Scientist |
Novo Nordisk
Lakshmi Kuttippurathu
Associate director, computational biology and data science | Lexicon Pharmaceuticals
Artem Evdokimov
Head of Research |
Orogen Therapeutics
Vittal Shivva
Director & Distinguished Scientist | Genentech
Hariprasad Vankayalapati
Chief Scientific Officer |
Biolexis Therapeutics, Inc.
Alex Pellerin
Director |
Seismic Therapeutic
David Bearss
CEO |
Halia Therapeutics
Niyanta Kumar
Principal Research Scientist
I-DMPK | ABBVIE
Aftabul Haque
Principal Scientist
| Biogen
Nevin Gerek Ince
Director |
Novo Nordisk
Colles Price
Associate Director
| Takeda
William Donaldson
CEO |
Estrigenix Therapeutics, Inc
Varnavas Mouchlis
Senior Scientist |
Bristol Myers Squibb
Daniela Cipolletta
Senior Director of Immunology | Seismic Therapeutic
Michael Liebman
Managing Director | IPQ Analytics. LLC
Dr Mark Varney
Chief Scientific Officer | Psycho Genics
Venkatesh Mysore
CTO | Aikium Inc.
Our Sponsors
Attendee Breakdown
Attendee Demographics
Agenda
06 May
Computer-Aided Drug Discovery
The Future of Pharmaceuticals
Advances in Targeted Protein Degradation for Drug Discovery
Future Perspectives for AI in the Drug Discovery
Proteomics Applications
Traditional Resources and Tools for Modern Drug Discovery
Different Approaches to Engage T Cells for Solid Tumors
07 May
